Bridgeway Capital Management’s Landos Biopharma, Inc. Common Stock LABP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,900
| Closed | -$11.6K | – | 1486 |
|
|
2023
Q1 | $11.6K | Sell |
3,900
-6,000
| -61% | -$17.9K | ﹤0.01% | 1368 |
|
|
2022
Q4 | $49.5K | Sell |
9,900
-5,000
| -34% | -$25K | ﹤0.01% | 1297 |
|
|
2022
Q3 | $97K | Hold |
14,900
| – | – | ﹤0.01% | 1275 |
|
|
2022
Q2 | $108K | Sell |
14,900
-1,000
| -6% | -$7.25K | ﹤0.01% | 1214 |
|
|
2022
Q1 | $235K | Buy |
+15,900
| New | +$235K | ﹤0.01% | 1143 |
|